masoprocol has been researched along with Lymphoma, Large-Cell, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceccato, L; Colomba, A; Delsol, G; Gaits-Iacovoni, F; Payrastre, B; Thornber, K | 1 |
1 other study(ies) available for masoprocol and Lymphoma, Large-Cell, Anaplastic
| Article | Year |
|---|---|
Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas.
Topics: Apoptosis; Arachidonate 5-Lipoxygenase; Cell Line, Tumor; Humans; Lipoxygenase Inhibitors; Lymphoma, Large-Cell, Anaplastic; Masoprocol; Protein-Tyrosine Kinases; Reactive Oxygen Species | 2009 |